Cargando…

Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report

BACKGROUND: Capecitabine has been commonly used in recurrent or metastatic nasopharyngeal carcinoma. However, radiation recall after capecitabine for nasopharyngeal carcinoma has not been reported. CASE PRESENTATION: We report the case of a 64-year-old Chinese woman with locoregionally advanced naso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Victor, Lam, Ka-On, Kwong, Dora, Leung, To-Wai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015341/ https://www.ncbi.nlm.nih.gov/pubmed/27604462 http://dx.doi.org/10.1186/s13256-016-1033-1

Ejemplares similares

Capecitabine-induced radiation recall phenomenon: a case report
por: Aguilar, José, et al.
Publicado: (2013)

Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma
por: Lee, Victor H. F., et al.
Publicado: (2016)

Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2016)

Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy
por: Chan, Sik-Kwan, et al.
Publicado: (2020)

The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis
por: Choi, Horace Cheuk-Wai, et al.
Publicado: (2021)

Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report
por: Lau, Kin-Sang, et al.
Publicado: (2021)

Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma
por: Lee, Victor H.F., et al.
Publicado: (2017)

Bevacizumab-containing regimens after cetuximab failure in Kras wild-type metastatic colorectal carcinoma
por: LAM, KA ON, et al.
Publicado: (2013)

Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer
por: Alshamsan, Bader, et al.
Publicado: (2022)

Salivary Anionic Changes after Radiotherapy for Nasopharyngeal Carcinoma: A 1-Year Prospective Study
por: Pow, Edmond H. N., et al.
Publicado: (2016)

Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes
por: Nicholls, John Malcolm, et al.
Publicado: (2019)

Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong—A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network
por: Chan, Sik-Kwan, et al.
Publicado: (2021)

The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial
por: Tang, Lin-Quan, et al.
Publicado: (2023)

Current Management Strategy of Nasopharyngeal Carcinoma
por: Wei, William I., et al.
Publicado: (2010)

Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma
por: Kim, Gwi Eon, et al.
Publicado: (2017)

Post-radiation sinusitis is associated with recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
por: Huang, Chih-Jen, et al.
Publicado: (2019)

Recurrent Radiation Recall Mucosal Toxicity of the Upper Aerodigestive Tract: A Case Report
por: McGrath, Laura A., et al.
Publicado: (2018)

The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation
por: Ravaioli, Matteo, et al.
Publicado: (2017)

Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: She, Longjiang, et al.
Publicado: (2022)

Pretreatment Nomograms for Local and Regional Recurrence after Radical Radiation Therapy for Primary Nasopharyngeal Carcinoma
por: Chen, Fo-ping, et al.
Publicado: (2017)

Radiation recall after COVID-19 infection
por: Ross, Richard Blake, et al.
Publicado: (2022)

Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical Trial
por: Miao, Jingjing, et al.
Publicado: (2022)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

Tozinameran: Radiation recall pneumonitis: case report
Publicado: (2022)

Aetiological factors and imaging program for severe radiation-induced extracranial carotid stenosis in nasopharyngeal carcinoma
por: Lam, W. W. M., et al.
Publicado: (2015)

Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma
por: Ka-Yue Chow, Larry, et al.
Publicado: (2022)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020)

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience
por: Guo, Qiaojuan, et al.
Publicado: (2020)

Pretreatment Prediction of Adaptive Radiation Therapy Eligibility Using MRI-Based Radiomics for Advanced Nasopharyngeal Carcinoma Patients
por: Yu, Ting-ting, et al.
Publicado: (2019)

An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma
por: Chan, Sik-Kwan, et al.
Publicado: (2022)

Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study
por: White, Peter, et al.
Publicado: (2013)

The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study
por: Sun, Xue‐Song, et al.
Publicado: (2020)

Solar Ultraviolet Radiation and Vitamin D Deficiency on Epstein-Barr Virus Reactivation: Observational and Genetic Evidence From a Nasopharyngeal Carcinoma-Endemic Population
por: Mai, Zhi-Ming, et al.
Publicado: (2020)

Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma
por: Chai, Annie Wai Yeeng, et al.
Publicado: (2016)

Secular trends of salted fish consumption and nasopharyngeal carcinoma: a multi-jurisdiction ecological study in 8 regions from 3 continents
por: Lau, Hiu-Ying, et al.
Publicado: (2013)

Radiation Recall Dermatitis after Treatment with Paclitaxel and Cisplatin
por: Baek, Seung Woo, et al.
Publicado: (2012)

Radiation recall pneumonitis after COVID‐19 vaccination
por: Shinada, Kanako, et al.
Publicado: (2021)

External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma
por: Yip, Pui-Lam, et al.
Publicado: (2021)

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial
por: Chiang, Chi Leung, et al.
Publicado: (2023)

Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small-cell lung cancer (NSCLC) previously responsive to first-generation tyrosine-kinase inhibitors (TKI) and chemotherapy: comparison with historical cohort using erlotinib
por: Lee, Victor H. F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0lsah03vvnuk501e4v5qr4ipss